PolyPid Ltd. announced the termination of its exclusive License, Distribution and Supply Agreement with ADVANZ PHARMA for its lead product, D-PLEX₁₀₀, in Europe, resulting in the reversion of ...
Opinion
Menopause Foundation of Canada Calls for Action with First-Ever Menopause Policy Agenda for Canada
The Menopause Foundation of Canada (MFC) is calling on governments across the country to act now to support millions of women experiencing menopause—a major health transition with far-reaching ...
More than a century after physicians first noticed that bacterial infections could sometimes shrink tumors, a new synthesis ...
Radiation-Induced Senescence in Radiopharmaceutical Therapy: Mechanisms and Therapeutic Implications
Radiopharmaceutical therapy (RPT) has emerged as a radiation therapy modality with the distinctive ability to systemically ...
Mouse skull bone marrow contains lymph node-like immune hubs that can respond quickly to brain cancer signals. These ...
Insurers are raising the bar for what patients need to demonstrate before expensive specialty medications are covered. Prior ...
*DEGEVMA is now FDA-approved across all indications of the reference product, Xgeva (denosumab), to help prevent bone ...
The International Development and Contemporary Re-evaluation of Morita Therapy - Developments in the West and China, and Dialogue with Mindfulness and ACT -Morita therapy is a form of psychotherapy ...
Dr. Chung to deliver an oral presentation highlighting QUELIMMUNE®, an advanced extracorporeal therapy for critically ill pediatric patients with acute kidney injury (AKI) ...
The New Era of Tumor-Agnostic Cancer Therapy / ALK, Allen Chen, BCR ABL, Bence Jones proteins, biomarkers, BRAF, CA 19-9, ...
Texas A&M researchers report an experimental MAP4K4 inhibitor that reduced fat buildup, inflammation, liver injury and ...
Simone Biles opens up about her experience managing the symptoms of these conditions and encourages long-term control of skin healthBiles’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results